Notable Analyst Rating Changes: ARO, CSX, PFWD, SIRI Upgraded; BRCD, BNI Downgraded
UPGRADES:
Goldman Sachs upgrades Aeropostale (NYSE: ARO) from Sell to Neutral but lowers their 6-month price target to $34 from $41. Click Here for more color.
Barclays upgrades CSX Corp. (NYSE: CSX) from Underweight to Equalweight and also raises its price target from $46 to $52.
UBS upgrades Phase Forward (NASDAQ: PFWD) to Buy and raised their price target from $14 to $20.
Late yesterday, S&P has revised its outlook on Sirius XM (NASDAQ: SIRI) from Stable to Positive.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
ThinkEquity, Piper Jaffray, and Lazard all downgraded Brocade Communications (NASDAQ: BRCD) to Hold, Neutral, and Hold, respectively. Piper set a price target of $9, down from $10 previously. For more from Piper, Click Here.
Barclays downgrades Burlington Northern Sante Fe (NYSE: BNI) from Equalweight to Underweight. Price target increased from $90 to $100.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Goldman Sachs initiates coverage on The Buckle, Inc. (NYSE: BKE) with a Sell rating and $27 downside price target.
Morgan Stanley initiates coverage on Merck (NYSE: MRK) with an Equalweight rating. Price target $34.
Wedbush initiates coverage on Abbott Laboratories (NYSE: ABT) with an Outperform rating. Price target $62. Click Here for more color.
Jesup & Lamont initiates coverage on Tiffany & Co. (NYSE: TIF) with a Hold. For more color, Click Here.
Dougherty & Co initiates coverage on FLIR Systems (NASDAQ: FLIR) with a Buy rating. Price target $35.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Create E-mail AlertRelated Categories
Special ReportsStocks Mentioned
+0.39
-0.20Related Entities
- Piper Jaffray
- UBS
- Morgan Stanley
- ThinkEquity
- Lazard
- Jesup & Lamont
- Standard & Poor's
- Barclays
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
